PortfoliosLab logoPortfoliosLab logo

L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF (BIOT.L) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with BIOT.L. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.

Cheapest Alternatives to BIOT.L

BIOT.L charges 0.49% annually. There are 24 ETFs in the Health & Biotech Equities category with lower expense ratios, going as low as 0.12%.


Best Risk-Adjusted Alternatives to BIOT.L

BIOT.L has a PortfoliosLab risk / return rank of 67. There are 10 ETFs in the Health & Biotech Equities category with higher risk-adjusted ranks, going as high as 91.


Top Performing BIOT.L Alternatives (YTD)

BIOT.L is at 8.27% YTD. There are 11 ETFs in the Health & Biotech Equities category with higher YTD returns, going as high as 22.10%.


Lowest Volatility Alternatives to BIOT.L

BIOT.L has 20.18% 1-year volatility. There are 21 ETFs in the Health & Biotech Equities category with lower 1-year volatility, going as low as 14.26%.


Lowest Drawdown Alternatives to BIOT.L

BIOT.L has a 1-year max drawdown of -9.55%. There are 5 ETFs in the Health & Biotech Equities category with shallower 1-year drawdowns, going as shallow as -6.89%.


Other ETFs from L&G

The 10 most viewed L&G ETFs shown here include LDGL.L, AUCO.L, RTWO.L and span 11 categories. AUM among these funds goes as high as $3B.


Compare BIOT.L with Any Fund or Stock

Compare BIOT.L with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


 

Diversifiers

Pair BIOT.L with funds that move differently

L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to BIOT.L.

Explore BIOT.L Diversifiers